We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+37.76%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$4.89B
AUM Growth
+$717M
(+17%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
40.48%
Holding
126
New
22
Increased
22
Reduced
35
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
+$41.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$37.3M |
| 3 |
Elevance Health
ELV
|
+$33.5M |
| 4 |
HELP
Cybin Inc
HELP
|
+$24.7M |
| 5 |
Bruker
BRKR
|
+$23.5M |
Top Sells
| 1 |
TERN
Terns Pharmaceuticals
TERN
|
+$125M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$65.8M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$51.6M |
| 4 |
Axsome Therapeutics
AXSM
|
+$38.9M |
| 5 |
SI-BONE Inc
SIBN
|
+$38M |
Sector Composition
| 1 | Healthcare | 99.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Janux Therapeutics
JANX
$975M
| $27M | 0.55% |
1,954,426
+188,326
| +11% | +$4.43M |
|
52
Thermo Fisher Scientific
TMO
$200B
| $26.9M | 0.55% |
46,500
| – | – |
|
|
53
Bruker
BRKR
$8.97B
| $26.2M | 0.54% |
+555,789
| New | +$23.5M |
|
54
Rhythm Pharmaceuticals
RYTM
$7.57B
| $25.7M | 0.53% |
239,800
+24,648
| +11% | +$2.61M |
|
55
Shattuck Labs
STTK
$606M
| $23M | 0.47% |
6,306,127
| – | – |
|
56
Esperion Therapeutics
ESPR
| $22.1M | 0.45% |
+5,965,498
| New | +$19.3M |
|
57
Avalo Therapeutics
AVTX
$970M
| $21.6M | 0.44% |
1,187,300
-162,000
| -12% | -$2.73M |
|
58
Lexeo Therapeutics
LXEO
$359M
| $21.1M | 0.43% |
+2,125,000
| New | +$19.4M |
|
59
ADC Therapeutics
ADCT
$158M
| $20.6M | 0.42% |
5,822,854
-84,497
| -1% | -$343K |
|
60
UroGen Pharma
URGN
$1.94B
| $20.5M | 0.42% |
875,487
+186,487
| +27% | +$4.05M |
|
61
Xenon Pharmaceuticals
XENE
$6.51B
| $20M | 0.41% |
447,200
+27,600
| +7% | +$1.16M |
|
62
BrightSpring Health Services
BTSG
$13.6B
| $18.3M | 0.37% |
488,500
+224,700
| +85% | +$7.54M |
|
63
Vera Therapeutics
VERA
$3.05B
| $17.9M | 0.37% |
+353,500
| New | +$12.6M |
|
64
uniQure
QURE
$2.79B
| $17.6M | 0.36% |
737,400
+278,900
| +61% | +$10.8M |
|
|
DFTX
65
Definium Therapeutics
DFTX
$6.07B
| $16.4M | 0.34% |
1,226,700
+858,876
| +234% | +$10.6M |
|
66
Keros Therapeutics
KROS
$208M
| $16.4M | 0.34% |
804,212
-214,522
| -21% | -$3.76M |
|
|
CARL
67
Carlsmed
CARL
$300M
| $15.5M | 0.32% |
1,252,600
| – | – |
|
68
CytomX Therapeutics
CTMX
$788M
| $15M | 0.31% |
3,525,650
-4,935,850
| -58% | -$18.8M |
|
69
Vir Biotechnology
VIR
$1.62B
| $14.4M | 0.29% |
2,380,715
| – | – |
|
70
BioCryst Pharmaceuticals
BCRX
$2.4B
| $13.6M | 0.28% |
1,741,800
+840,300
| +93% | +$6.07M |
|
71
Cogent Biosciences
COGT
$6.7B
| $13.2M | 0.27% |
+371,000
| New | +$10.4M |
|
72
Corbus Pharmaceuticals
CRBP
$165M
| $13M | 0.27% |
1,597,287
+425,000
| +36% | +$5.25M |
|
73
Tarsus Pharmaceuticals
TARS
$2.41B
| $12.6M | 0.26% |
154,400
-43,500
| -22% | -$3.25M |
|
74
Relmada Therapeutics
RLMD
$645M
| $12.6M | 0.26% |
+2,610,600
| New | +$8.75M |
|
|
TECX
75
Tectonic Therapeutic
TECX
$622M
| $12M | 0.25% |
+574,600
| New | +$10.7M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM